Our specialisms


Drug delivery

We have an unparalleled track record in creating drug delivery devices that disrupt markets and revolutionize healthcare. These range from respiratory products, such as metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and nebulisers, to parenteral delivery devices including pens, autoinjectors, patch pumps and large volume injectors.

We have also pioneered high functionality, user-centred electromechanical devices combining drug delivery with wireless connectivity and eHealth service solutions to enable patient engagement and adherence. 

Diagnostics

We enable our clients to develop advanced, next-generation diagnostic devices that disrupt the status quo.

We work with our clients to revolutionize the management of chronic and acute diseases, bringing molecular diagnostics closer to the Point of Care (PoC) and developing liquid biopsy systems that transform cancer care and prenatal screening.  

Medical devices

We’re revolutionising therapy through ground-breaking surgical devices, implants and acute care platforms, spanning general surgery, vascular and cardiac surgery, orthopaedics, ophthalmology and neurology.

From through-body wireless telemetry to surgical robotics, our technical and commercial expertise combined with deep clinical, procedural and workflow understanding consistently leads to systems that excel in real-world clinical environments. 

Digital health

We help our healthcare clients develop robust, scalable platforms capable of handling large amounts of data from devices, leveraging recent advancements in connectivity, data science, machine learning and digital services.

We also provide strategic advice on long-term strategic roadmaps, business system integration, digital transformation and go-to-market strategies. 

How we work


Our world-class multidisciplinary teams bring deep technical, commercial, clinical, regulatory, user and workflow insights, combined with a thorough understanding of integrating usability, viability, desirability and performance requirements.

Our designers and engineers – fluent in design for manufacture (DFM) – work closely with external partners to ensure seamless transfer to manufacture.

With long experience in this highly regulated sector, our proven quality, project and risk management systems deliver fast and fully compliant programmes to FDA QSR and ISO 13485. 

Interested in joining us? 

Tech, tools & facilities


Surgical innovation suite
 

Surgical innovation suite

Equipped to simulate clinical, home and office environments, this facility allows us to test concepts, evaluate prototypes and analyse workflows in a safe and confidential setting. It’s an invaluable tool for understanding and communicating the contextual implications of design decisions, while the ability to conduct quick-turnaround usability evaluations means we can efficiently progress design and development.

Life Science Labs
 

Life science labs

Our suite of restricted Class II laboratories are specifically designed for handling and experimentation of pharmaceuticals, licensed substances, biological hazards and human samples in a controlled and regulated environment. Our instrumentation rooms are equipped with metrology, microscopy and product test equipment for rigorous verification and quality assurance of prototypes and products.

Prototyping workshops
 

プロトタイプ生産工場

プロトタイプ生産工場(電子基板・メカ)では、アイデアを実現し、製品価値を説得力をもって実証するプロトタイプを生産しています。試作品は、ISO 9001、ISO 13485、およびISO 14001規制に準拠した極めて高い品質基準を維持しています。最新のCNCおよびフライス盤、旋盤、溶接ギア、ワイヤーハーネス、ケーブルアセンブリツールを使用することにより素早くパーツを製造し、検証作業やユーザートライアル用向けに実物大で動作可能なプロトタイプを組み立てることができます。

Electronic production
 

Electronic production

Our flexible, responsive and agile manufacturing facilities are ideally suited to electronic and electromechanical product builds, enabling us to very quickly set up short product runs built to an extremely high quality. We can build our own PCBAs using industrial representative equipment and ensure manufacture-ability during design. Having our own EPD facility is also extremely helpful in development, driving out DfX activities in eCAD, and feeding test results back into the design process from an early stage.

Optics labs
 

Optics labs

Our suite optics labs enable us to build complex and high-precision optical layouts, typically for testing prototype designs and novel techniques prior to deployment. Featuring six high-spec optical benches with configurable interlocked controlled areas for high-power (class 4) laser work and specialist facilities for interferometry, spectroscopy, low-noise fluorescence imaging and photon counting. This space can be split into separate laser-controlled areas, allowing multiple experiments to run simultaneously, giving our optical engineers the capability to develop creative solutions without instrumentation restrictions.

Anechoic chamber (Stargate Satimo)
 

Satimo Stargate 64

無響無線・アンテナ試験を行う電波暗室 ”Satimo Stargate 64”は、ヨーロッパでも数少ない施設です。6m立法の空間で、無線デバイスからの電波伝播を自動で三次元測定・視覚化することができ、ウェアラブル技術のテストを人体模型または実際の被験者に対して行うことができます。スマートインプラント(埋め込みテレメトリをなど)、投薬デバイス、ウェアラブルなどの製品開発において、実際にRF性能を確認し最適化することができます。

We can help you achieve the impossible

CASE STUDIES


Axsis
 

コンセプト - 超小型手術支援ロボット“AXSIS”

Axsisは高度な知能を備えたロボット設計の可能性を実証しています。そのロボットは既存のシステムよりも大幅に小型化しながらも飛躍的に機能性が増しています。

 

Smart health monitoring wearable

Capturing data and applying machine learning algorithms to better understand stress and deliver more effective drug treatment

 

Wireless charging for implants

Near-field, inductively coupled design for deep tissue neuromodulation system.

 

Novartis auto-injector design

Intuitive drug delivery device for multiple sclerosis sufferers

NEWS & INSIGHTS


Opinion

Exploring the potential for non-contact monitoring for sepsis, the quick and costly killer

17th January 2020

Sepsis is a life-threatening response of the immune system to infection that can lead to tissue damage, organ failure and the risk of permanent disability or death. Detecting and treating it early can be highly effective in stopping progression. The trouble is that implementing the level of monitoring required to catch sepsis at the earliest stages is tough outside critical care settings. 

  • AI & Analytics
  • Connectivity & IoT
  • Digital health
  • Sensing
  • Signal processing
Webinar

The what, why and how of connected medical implant development for personalized delivery of medicine

12th November 2019

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

  • Connectivity & IoT
  • Digital health
  • Product realisation
Whitepaper

Chiplets: the path to IoT diversity

3rd October 2019

In this whitepaper, we explore why chiplets offer a path towards increased IoT diversity, bringing benefits to original equipment manufacturers (OEMs) and semiconductor companies alike.

  • AI & Analytics
  • Connectivity & IoT
  • Electronics & ASICs
  • Product realisation
Whitepaper

患者モニタリングシステムの未来

19th November 2019

患者管理にはモニタリングが不可欠です。モニタリングで得られる断続的かつ継続的な情報は、様々な用途で使用されます。病態を明確にしたり、治療方法を患者さんや関係者に説明したり、その後の治療が順調かどうか判断したりすることができます。

  • 機械学習&AI
  • コネクティビティ&IoT
  • デジタルヘルス
  • デジタルセキュリティー
  • デジタルサービス
  • ヒューマンファクター
  • 製品の実現
  • センシング
  • サービスデザイン
  • ユーザーエクスペリエンス